Skip to content

Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine

Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine Uptake in Underserved Communities in Greece, The Netherlands, Poland and Slovakia

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06361628
Acronym
RIVER-EU
Enrollment
1000
Registered
2024-04-12
Start date
2024-05-01
Completion date
2025-06-01
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Systems, Knowledge, Attitudes, Practice, Vaccination

Brief summary

The goal of the study is to monitor and evaluate the implementation of interventions that aim to increase HPV & MMR vaccines among underserved communities across four European countries: Greece, Netherlands, Poland, and Slovakia. The interventions will target identified health systems barriers in an earlier phase of the project. The interventions that will be implemented employ trusted community members as health promotors whom will provide educational sessions on HPV and MMR vaccination to the target groups. In addition, the cost-effectiveness of vaccine uptake strategies for the target groups is being evaluated. The main research question is: to what extent is the multicomponent tailored intervention effective to increase MMR/HPV intention and vaccine uptake in the target population in Greece, Netherlands, Poland and Slovakia?

Detailed description

The general objective of the study is to improve access to vaccination by addressing relevant system level barriers to increase HPV and MMR (where applicable) vaccine intention and uptake among the target groups. The investigators expect that the intervention will address health system barriers to improve increase in access to information on vaccination and vaccination services. A prospective multicomponent intervention study will be performed between 1st of April 2024 and 31st of July 2025 that will be evaluated using a pre and post design as well as a participatory approach during the implementation. As part of the multicomponent intervention a preparatory phase is taken place before this period of time. The multicomponent intervention consists of training of health promotors and healthcare professionals, and of educational sessions to community members and navigation. The educational sessions will be offered at suitable and accessible locations for the target population. The five communities targeted in are the following: 1. The migrant community in Greece (HPV and MMR) 2. Turkish and Moroccan women in the Netherlands (HPV) 3. The Ukrainian community in Poland (HPV and MMR) 4. The Roma community in Slovakia (HPV)

Interventions

BEHAVIORALmulticomponent intervention on vaccination awareness

Educational sessions to create awareness on HPV and MMR (were addressed) vaccination that is culturally sensitive health information and provided in an easily understandable manner by trained health promoters (and healthcare professionals) to underserved communities. Support for navigation and access to vaccines.

Sponsors

Prolepsis Institute for Preventive, Environmental and Occupational Medicine
CollaboratorOTHER
University in Zielona Góra
CollaboratorOTHER
Pavol Jozef Safarik University
CollaboratorOTHER
University Medical Center Groningen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* parents of children eligible for MMR and/or HPV vaccination according to country guidelines on those specific vaccines

Exclusion criteria

* respondents not willing or able to fill out questionnaires

Design outcomes

Primary

MeasureTime frameDescription
Intention to vaccinate MMR and/or HPV by questionnairePre and immediately following the intervention and 6 month post interventionIntention for vaccination against MMR and/or HPV among the underserved communities

Secondary

MeasureTime frameDescription
Uptake of MMR and/or HPV vaccinations by questionnairePre and 6 month post intervention evaluation is necessaryMMR and/or HPV vaccination uptake among the underserved communities
Knowledge concerning MMR and/or HPV vaccinations in the target group using a questionnairePre and immediately following the intervention and 6 month post intervention evaluationKnowledge concerning MMR and/or HPV vaccinations among the target group
Communication skills of health care professionals using a questionnairePre intervention and directly post interventionCommunication skills of healthcare professionals to deliver appropriate information
Satisfaction of the stakeholders as measured by a questionnaireDirectly post interventionSatisfaction of stakeholders (health promotors and health professionals) with the implementation process and the intervention itself

Other

MeasureTime frameDescription
Improved access to vaccinations by addressing identified health system barriers - number of barriers addressedThrough study completion, an average of 1 yearAddressed health system barriers to improve access to MMR and/or HPV vaccinations among the underserved communities

Countries

Greece, Netherlands, Poland, Slovakia

Contacts

Primary ContactJanine De Zeeuw, PhD
j.de.zeeuw@umcg.nl+31 645552994
Backup ContactPania Karnaki
p.karnaki@prolepsis.gr+30 210 6255700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026